Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Targeting Oncogenic Enhancers in ASXL1 -Mutant Chronic Myelomonocytic Leukemia

Terra L Lasho, Christy M Finke, Jenna A. Fernandez, Christopher T. Schmitz, Karl J. Clark, Claes Wahlestedt, Judy Chiao, Abhishek A Mangaonkar, Mrinal M. Patnaik, Moritz Binder

Blood (2023) 142 (Supplement 1): 1413.

https://doi.org/10.1182/blood-2023-178083

Published: 2023

Journal Articles

Ruxolitinib Versus Best Available Therapy for PV Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

Blood (2022) 140 (Supplement 1): 1781–1783.

https://doi.org/10.1182/blood-2022-157273

Published: 2022

Journal Articles

Effects of Tamoxifen on the Mutant Allele Burden and Disease Course in Patients with Myeloproliferative Neoplasms - Results of the Tamarin Study

Claire Harrison, DM, FRCP, FRCPath, Joanna Baxter, PhD, Rebecca H. Boucher, BSc, MSc, PhD, Thomas McKerrell, MD PhD, Aimee Jackson, BSc, MSc, Rachel S Fletcher, PhD, Adam J. Mead, MD PhD, Steve Knapper, BMBCh, MRCP, FRCPath, DM, Joanne Ewing, MD PhD, Nauman M Butt, MD, Manish Jain, MBBS, MRCP, FRCpath, Sebastian Francis, MBChB, FRCPath, MD, Fiona J Clark, FRCP, FRCPath, Jason Coppell, MBBS, Mary Frances McMullin, MDFRCP, FRCPath, Frances Wadelin, MB ChB, PhD FRCPath, Srinivasan Narayanan, FRCP, FRCPath, Dragana Milojkovic, Mark W. Drummond, PhD FRCPath, Mallika Sekhar, MBBS, MD, Maike Paramor, James Roberts, BSc, Rachel Glover, BSc, Erica Harris, MSc, Luigi Grassi, PhD, Alba Rodriguez-Meira, PhD, Jason Carroll, PhD FMedSci, José-Ezequiel Martín, PhD, Giuditta Corbizi Fattori, PhD, Zijian Fang, BSc, Anna L Godfrey, BMBCh, PhD, Simón Méndez-Ferrer, PhD

Blood (2020) 136 (Supplement 1): 33–35.

https://doi.org/10.1182/blood-2020-134764

Published: 2020

Journal Articles

Phazar: A Phase Ib Study to Assess the Safety and Tolerability of Ruxolitinib in Combination with Azacitidine in Advanced Phase Myeloproliferative Neoplasms (MPN), Including Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukaemia (AML) Arising from MPN [ISRCTN16783472]

Mark W. Drummond, PhD FRCPath, Charlotte Gaskell, BSc, MSc, Claire Harrison, DM, FRCP, FRCPath, Adam J. Mead, MD PhD, Christina Yap, PhD CStat, Aimee E Jackson, BSc, MSc, Jennifer Byrne, FRCP, FRCPath, PhD, Fiona J Clark, FRCP, FRCPath, Srinivasan Narayanan, FRCP, FRCPath, David Bowen, MD, Tim C.P Somervaille, PhD FRCP, FRCPath, Emma Gudgin, MBBS, MRCP, FRCPath, PhD, Dragana Milojkovic, Rachel S Fletcher, PhD, Charlotte K Brierley, MRCP, MD, Steve Knapper, BMBCh, MRCP, FRCPath, DM

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-138437

Published: 2020

Journal Articles

A Blood Dendritic Cell Vaccine for Acute Myeloid Leukemia Expands Anti-Tumour T Cell Responses at Remission

Derek NJ Hart, PhD FRCPA, FRACP, MB, Jennifer L Hsu, Christian E Bryant, Michael S Papadimitrious, Benjamin Kong, Robin E Gasiorowski, Daniel W Orellana, Helen McGuire, Barbara Fazekas de St Groth, Douglas E. Joshua, Phoebe Joy Ho, Stephen R Larsen, Harry J Iland, John Gibson, Georgina J Clark, Phillip D Fromm

Blood (2017) 130 (Supplement 1): 2648.

https://doi.org/10.1182/blood.V130.Suppl_1.2648.2648

Published: 2017

Journal Articles

An ABVD-Based Approach Confers Superior Outcomes for Adolescent and Young Adult Patients Compared to Other Adults with Advanced Classical Hodgkin Lymphoma

David M Burns, BSc,MBBS,MRCP, Andrew Bacon, BSc, MSc, Timothy HT Wong, MBBChir, Guy Pratt, MD FRCP, FRCPath, Fiona J Clark, MBBChir, FRCP, FRCPath, Premini Mahendra, MD FRCP, FRCPath, Sridhar Chaganti, MDPhDMRCP,FRCPath, Ram Malladi, MRCP, FRCPath, PhD

Blood (2017) 130 (Supplement 1): 4083.

https://doi.org/10.1182/blood.V130.Suppl_1.4083.4083

Published: 2017

Journal Articles

GATA2 Mutations In Pediatric Myelodysplastic Syndromes and Bone Marrow Failure

Inga Hofmann, MD, Daniel Kierstead, Jennie Krasker, Dean Campagna, Klaus Schmitz-Abe, PhD, Kyriacos Markianos, PhD, Michelle A Lee, MD, PhD, Colin A. Sieff, MD, Suneet Agarwal, MD, PHD, Jennifer J Clark, MD, Michael Jeng, MD, Mignon L. Loh, MD, Evan Shereck, MD, David A. Williams, MD, Mark D Fleming, D.Phil., M.D.

Blood (2013) 122 (21): 1520.

https://doi.org/10.1182/blood.V122.21.1520.1520

Published: 2013

Journal Articles

Whole Genome Sequence Analysis of Primary Myelofibrosis.

Jason D. Merker, Krishna Roskin, Dana Ng, Cuiping Pan, Dianna G. Fisk, Carol D. Jones, Linda Gojenola, Michael J. Clark, Bing Zhang, Michael Cherry, Michael Snyder, Scott D. Boyd, James L. Zehnder, Andrew Z. Fire, Jason Gotlib

Blood (2012) 120 (21): 2863.

https://doi.org/10.1182/blood.V120.21.2863.2863

Published: 2012

Journal Articles

Revealing the role of phospholipase Cβ3 in the regulation of VEGF-induced vascular permeability

Luke H. Hoeppner, Kathryn N. Phoenix, Karl J. Clark, Resham Bhattacharya, Xun Gong, Tracey E. Sciuto, Pawan Vohra, Sandip Suresh, Santanu Bhattacharya, Ann M. Dvorak, Stephen C. Ekker, Harold F. Dvorak, Kevin P. Claffey, Debabrata Mukhopadhyay

Blood (2012) 120 (11): 2167–2173.

https://doi.org/10.1182/blood-2012-03-417824

Published: 2012

Includes: Multimedia, Supplemental data

Journal Articles

Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds

Lai Y. Chan, Sunithi Gunasekera, Sonia T. Henriques, Nathalie F. Worth, Sarah-Jane Le, Richard J. Clark, Julie H. Campbell, David J. Craik, Norelle L. Daly

Blood (2011) 118 (25): 6709–6717.

https://doi.org/10.1182/blood-2011-06-359141

Published: 2011

Includes: Supplemental data

Journal Articles

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

Shaji Kumar, Angela Dispenzieri, Jerry A. Katzmann, Dirk R. Larson, Colin L. Colby, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Nelson Leung, Steve R. Zeldenrust, Marina Ramirez-Alvarado, Raynell J. Clark, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz

Blood (2010) 116 (24): 5126–5129.

https://doi.org/10.1182/blood-2010-06-290668

Published: 2010

Journal Articles

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

Ola Landgren, Robert A. Kyle, Ruth M. Pfeiffer, Jerry A. Katzmann, Neil E. Caporaso, Richard B. Hayes, Angela Dispenzieri, Shaji Kumar, Raynell J. Clark, Dalsu Baris, Robert Hoover, S. Vincent Rajkumar

Blood (2009) 113 (22): 5412–5417.

https://doi.org/10.1182/blood-2008-12-194241

Published: 2009

Journal Articles

Structural Aspects of Hepcidin-Ferroportin Binding

Gloria Preza, Augustine Fernandes, PhD, Richard J. Clark, PhD, David J. Craik, PhD, Tomas Ganz, MD, PhD, Elizabeta Nemeth, PhD

Blood (2008) 112 (11): 119.

https://doi.org/10.1182/blood.V112.11.119.119

Published: 2008

Journal Articles

CD300a/c regulate type I interferon and TNF-α secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands

Xinsheng Ju, Martin Zenke, Derek N. J. Hart, Georgina J. Clark

Blood (2008) 112 (4): 1184–1194.

https://doi.org/10.1182/blood-2007-12-127951

Published: 2008

Includes: Supplemental data

Journal Articles

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

Angela Dispenzieri, Robert A. Kyle, Jerry A. Katzmann, Terry M. Therneau, Dirk Larson, Joanne Benson, Raynell J. Clark, L. Joseph Melton, III, Morie A. Gertz, Shaji K. Kumar, Rafael Fonseca, Diane F. Jelinek, S. Vincent Rajkumar

Blood (2008) 111 (2): 785–789.

https://doi.org/10.1182/blood-2007-08-108357

Published: 2008

Journal Articles

Uniform sensitivity of FLT3 activation loop mutants to the tyrosine kinase inhibitor midostaurin

Elly V. Barry, Jennifer J. Clark, Jan Cools, Johannes Roesel, D. Gary Gilliland

Blood (2007) 110 (13): 4476–4479.

https://doi.org/10.1182/blood-2007-07-101238

Published: 2007

Includes: Supplemental data

Journal Articles

Novel Human CD4 + T Lymphocyte Subpopulations Defined by CD300a/c Molecule Expression.

Derek N.J. Hart, MBBS, PhD, Min Rao, Xinsheng Ju, Georgina J. Clark, PhD

Blood (2007) 110 (11): 2304.

https://doi.org/10.1182/blood.V110.11.2304.2304

Published: 2007

Journal Articles

Prognostic Value of the Serum Free Light Chain Ratio in Patients with Newly Diagnosed Myeloma: Proposed Incorporation into the International Staging System.

Christine L.H. Snozek, PhD, Jerry A. Katzmann, PhD, Robert A. Kyle, MD, Angela Dispenzieri, MD, Dirk R. Larson, Raynell J. Clark, Philip R. Greipp, MD, S. Vincent Rajkumar, MD

Blood (2007) 110 (11): 659.

https://doi.org/10.1182/blood.V110.11.659.659

Published: 2007

Journal Articles

MMRI-23: A Potential Role in AML Antibody-Mediated Therapy.

Courtney J. Modra, BSc (Hons), Lubomira Jamriska, PhD, Min Rao, BSc, Georgina J. Clark, PhD, Derek N.J. Hart, MBBS, DPhil

Blood (2006) 108 (11): 4581.

https://doi.org/10.1182/blood.V108.11.4581.4581

Published: 2006

Journal Articles

Ceramide Kinase Promotes Store Dependent Ca 2+ Signals and Enhances Phagolysosomal Fusion in COS-1 Cells.

Vania T. Hinkovska-Galcheva, PhD, Andrea J. Clark, M.S., Andrei L. Kindzelskii, MD, Ph.D, Susan M. VanWay, Ph.D, JiBiao Huang, M.S., Thomas P. Shanley, MD, James A. Shayman, MD, Howard R. Petty, Ph.D, Laurence A. Boxer, MD

Blood (2006) 108 (11): 1629.

https://doi.org/10.1182/blood.V108.11.1629.1629

Published: 2006

NARROW

Targeting Oncogenic Enhancers in ASXL1 -Mutant Chronic Myelomonocytic Leukemia

Ruxolitinib Versus Best Available Therapy for PV Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

Effects of Tamoxifen on the Mutant Allele Burden and Disease Course in Patients with Myeloproliferative Neoplasms - Results of the Tamarin Study

Phazar: A Phase Ib Study to Assess the Safety and Tolerability of Ruxolitinib in Combination with Azacitidine in Advanced Phase Myeloproliferative Neoplasms (MPN), Including Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukaemia (AML) Arising from MPN [ISRCTN16783472]

A Blood Dendritic Cell Vaccine for Acute Myeloid Leukemia Expands Anti-Tumour T Cell Responses at Remission

An ABVD-Based Approach Confers Superior Outcomes for Adolescent and Young Adult Patients Compared to Other Adults with Advanced Classical Hodgkin Lymphoma

GATA2 Mutations In Pediatric Myelodysplastic Syndromes and Bone Marrow Failure

Whole Genome Sequence Analysis of Primary Myelofibrosis.

Revealing the role of phospholipase Cβ3 in the regulation of VEGF-induced vascular permeability

Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

Structural Aspects of Hepcidin-Ferroportin Binding

CD300a/c regulate type I interferon and TNF-α secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

Uniform sensitivity of FLT3 activation loop mutants to the tyrosine kinase inhibitor midostaurin

Novel Human CD4 + T Lymphocyte Subpopulations Defined by CD300a/c Molecule Expression.

Prognostic Value of the Serum Free Light Chain Ratio in Patients with Newly Diagnosed Myeloma: Proposed Incorporation into the International Staging System.

MMRI-23: A Potential Role in AML Antibody-Mediated Therapy.

Ceramide Kinase Promotes Store Dependent Ca 2+ Signals and Enhances Phagolysosomal Fusion in COS-1 Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only